As reported at IDWeek 2023 and in The Lancet Diabetes & Endocrinology, people taking semaglutide experienced notable declines in weight, total body fat and visceral abdominal fat, while those in the placebo group saw little change or slight gains
localised swelling, bruising, and discomfort at the injection site
As discussed, gutliver axis is an important bridge between gut and liver
Trends Cardiovasc Med 33(3):159166 De Hollanda BA, Prizo VM, de Souza MD, Mendes BX, Defante ML, Martins OC, Rodrigues AM (2024) The efficacy and safety of GLP-1 agonists in PCOS women living with obesity in promoting weight loss and hormonal regulation: a meta-analysis of randomized controlled trials
By taking it in the morning, you allow your body to better process it and maintain its natural circadian rhythm